APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tumor Fluid Biopsy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tumor Fluid Biopsy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025199 pages

Choose your research edition.

Industry ResearchTumor Fluid Biopsy Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Fluid Biopsy Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Tumor Fluid Biopsy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Fluid Biopsy Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Tumor Fluid Biopsy Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Tumor Fluid Biopsy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Tumor Fluid Biopsy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tumor Fluid Biopsy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor Fluid Biopsy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tumor Fluid Biopsy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tumor Fluid Biopsy include Cellmax Life, Exact Science, Amoy Diagnostics Co, Berry Genomics Co, Genetronhealth, GenoploRare, HaploX Biotechnology Co, New Horizon Health Limited and Burning Rock Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Tumor Fluid Biopsy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tumor Fluid Biopsy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tumor Fluid Biopsy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Tumor Fluid Biopsy market size, projected growth trends, production technologies, key applications, and end-use industries.

Tumor Fluid Biopsy Segment by Company

Cellmax Life

Exact Science

Amoy Diagnostics Co

Berry Genomics Co

Genetronhealth

GenoploRare

HaploX Biotechnology Co

New Horizon Health Limited

Burning Rock Biotech

Guangzhou Wondfo Biotech

YZY Biopharma

Tumor Fluid Biopsy Segment by Type

CTDNA Detection

CTC Detection

Other

Tumor Fluid Biopsy Segment by Application

Hospital

Third Party Organization

Other

Tumor Fluid Biopsy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Fluid Biopsy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Fluid Biopsy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Fluid Biopsy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tumor Fluid Biopsy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor Fluid Biopsy industry.

Chapter 3: Detailed analysis of Tumor Fluid Biopsy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Fluid Biopsyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tumor Fluid Biopsy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of CTDNA Detection Table 3. Key Players of CTC Detection Table 4. Key Players of Other Table 4. Global Tumor Fluid Biopsy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Third Party Organization Table 7. Key Players of Other Table 8. Global Tumor Fluid Biopsy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Tumor Fluid Biopsy Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Tumor Fluid Biopsy Market Share by Region (2021-2026) Table 11. Global Tumor Fluid Biopsy Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Tumor Fluid Biopsy Market Share by Region (2027-2032) Table 13. Tumor Fluid Biopsy Industry Trends Table 14. Tumor Fluid Biopsy Industry Drivers Table 15. Tumor Fluid Biopsy Industry Opportunities and Challenges Table 16. Tumor Fluid Biopsy Industry Restraints Table 17. Global Tumor Fluid Biopsy Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Tumor Fluid Biopsy Revenue Market Share by Company (2021-2026) Table 19. Global Tumor Fluid Biopsy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Tumor Fluid Biopsy Key Company Head Office and Area Served Table 21. Global Tumor Fluid Biopsy Company, Product Type & Application Table 22. Global Tumor Fluid Biopsy Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Tumor Fluid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Tumor Fluid Biopsy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Tumor Fluid Biopsy Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Tumor Fluid Biopsy Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Tumor Fluid Biopsy Revenue Market Share by Type (2021-2026) Table 29. Global Tumor Fluid Biopsy Revenue Market Share by Type (2027-2032) Table 30. Global Tumor Fluid Biopsy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Tumor Fluid Biopsy Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Tumor Fluid Biopsy Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Tumor Fluid Biopsy Revenue Market Share by Application (2021-2026) Table 34. Global Tumor Fluid Biopsy Revenue Market Share by Application (2027-2032) Table 35. Cellmax Life Company Information Table 36. Cellmax Life Business Overview Table 37. Cellmax Life Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Cellmax Life Tumor Fluid Biopsy Product Portfolio Table 39. Cellmax Life Recent Development Table 40. Exact Science Company Information Table 41. Exact Science Business Overview Table 42. Exact Science Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Exact Science Tumor Fluid Biopsy Product Portfolio Table 44. Exact Science Recent Development Table 45. Amoy Diagnostics Co Company Information Table 46. Amoy Diagnostics Co Business Overview Table 47. Amoy Diagnostics Co Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Amoy Diagnostics Co Tumor Fluid Biopsy Product Portfolio Table 49. Amoy Diagnostics Co Recent Development Table 50. Berry Genomics Co Company Information Table 51. Berry Genomics Co Business Overview Table 52. Berry Genomics Co Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Berry Genomics Co Tumor Fluid Biopsy Product Portfolio Table 54. Berry Genomics Co Recent Development Table 55. Genetronhealth Company Information Table 56. Genetronhealth Business Overview Table 57. Genetronhealth Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Genetronhealth Tumor Fluid Biopsy Product Portfolio Table 59. Genetronhealth Recent Development Table 60. GenoploRare Company Information Table 61. GenoploRare Business Overview Table 62. GenoploRare Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. GenoploRare Tumor Fluid Biopsy Product Portfolio Table 64. GenoploRare Recent Development Table 65. HaploX Biotechnology Co Company Information Table 66. HaploX Biotechnology Co Business Overview Table 67. HaploX Biotechnology Co Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. HaploX Biotechnology Co Tumor Fluid Biopsy Product Portfolio Table 69. HaploX Biotechnology Co Recent Development Table 70. New Horizon Health Limited Company Information Table 71. New Horizon Health Limited Business Overview Table 72. New Horizon Health Limited Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. New Horizon Health Limited Tumor Fluid Biopsy Product Portfolio Table 74. New Horizon Health Limited Recent Development Table 75. Burning Rock Biotech Company Information Table 76. Burning Rock Biotech Business Overview Table 77. Burning Rock Biotech Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Burning Rock Biotech Tumor Fluid Biopsy Product Portfolio Table 79. Burning Rock Biotech Recent Development Table 80. Guangzhou Wondfo Biotech Company Information Table 81. Guangzhou Wondfo Biotech Business Overview Table 82. Guangzhou Wondfo Biotech Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Guangzhou Wondfo Biotech Tumor Fluid Biopsy Product Portfolio Table 84. Guangzhou Wondfo Biotech Recent Development Table 85. YZY Biopharma Company Information Table 86. YZY Biopharma Business Overview Table 87. YZY Biopharma Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. YZY Biopharma Tumor Fluid Biopsy Product Portfolio Table 89. YZY Biopharma Recent Development Table 90. North America Tumor Fluid Biopsy Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Tumor Fluid Biopsy Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Tumor Fluid Biopsy Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Tumor Fluid Biopsy Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Tumor Fluid Biopsy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Tumor Fluid Biopsy Market Size by Country (2021-2026) Table 96. North America Tumor Fluid Biopsy Market Size by Country (2027-2032) Table 97. Europe Tumor Fluid Biopsy Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Tumor Fluid Biopsy Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Tumor Fluid Biopsy Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Tumor Fluid Biopsy Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Tumor Fluid Biopsy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Tumor Fluid Biopsy Market Size by Country (2021-2026) Table 103. Europe Tumor Fluid Biopsy Market Size by Country (2027-2032) Table 104. China Tumor Fluid Biopsy Market Size by Type (2021-2026) & (US$ Million) Table 105. China Tumor Fluid Biopsy Market Size by Type (2027-2032) & (US$ Million) Table 106. China Tumor Fluid Biopsy Market Size by Application (2021-2026) & (US$ Million) Table 107. China Tumor Fluid Biopsy Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Tumor Fluid Biopsy Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Tumor Fluid Biopsy Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Tumor Fluid Biopsy Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Tumor Fluid Biopsy Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Tumor Fluid Biopsy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Tumor Fluid Biopsy Market Size by Country (2021-2026) Table 114. Asia Tumor Fluid Biopsy Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Tumor Fluid Biopsy Product Image Figure 2. Global Tumor Fluid Biopsy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Tumor Fluid Biopsy Market Share by Type: 2025 VS 2032 Figure 4. CTDNA Detection Image Figure 5. CTC Detection Image Figure 6. Other Image Figure 7. Global Tumor Fluid Biopsy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Tumor Fluid Biopsy Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Third Party Organization Image Figure 11. Other Image Figure 12. Global Tumor Fluid Biopsy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 14. Global Tumor Fluid Biopsy Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Tumor Fluid Biopsy Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Tumor Fluid Biopsy Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Tumor Fluid Biopsy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Tumor Fluid Biopsy Revenue Market Share by Type (2021-2032) Figure 21. Global Tumor Fluid Biopsy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Tumor Fluid Biopsy Revenue Market Share by Application (2021-2032) Figure 23. North America Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 24. North America Tumor Fluid Biopsy Market Share by Type (2021-2032) Figure 25. North America Tumor Fluid Biopsy Market Share by Application (2021-2032) Figure 26. North America Tumor Fluid Biopsy Market Share by Country (2021-2032) Figure 27. United States Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 28. Canada Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 30. Europe Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 31. Europe Tumor Fluid Biopsy Market Share by Type (2021-2032) Figure 32. Europe Tumor Fluid Biopsy Market Share by Application (2021-2032) Figure 33. Europe Tumor Fluid Biopsy Market Share by Country (2021-2032) Figure 34. Germany Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 35. France Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 37. Italy Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 38. Russia Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 40. China Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 41. China Tumor Fluid Biopsy Market Share by Type (2021-2032) Figure 42. China Tumor Fluid Biopsy Market Share by Application (2021-2032) Figure 43. Asia Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 44. Asia Tumor Fluid Biopsy Market Share by Type (2021-2032) Figure 45. Asia Tumor Fluid Biopsy Market Share by Application (2021-2032) Figure 46. Asia Tumor Fluid Biopsy Market Share by Country (2021-2032) Figure 47. Japan Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 51. India Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 52. Australia Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Tumor Fluid Biopsy Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Tumor Fluid Biopsy Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Tumor Fluid Biopsy Market Share by Country (2021-2032) Figure 57. Brazil Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 62. UAE Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 64. Chile Tumor Fluid Biopsy Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • CTDNA Detection
  • CTC Detection
  • Other
Applications
  • Hospital
  • Third Party Organization
  • Other
Companies covered
  • Cellmax Life
  • Exact Science
  • Amoy Diagnostics Co
  • Berry Genomics Co
  • Genetronhealth
  • GenoploRare
  • HaploX Biotechnology Co
  • New Horizon Health Limited
  • Burning Rock Biotech
  • Guangzhou Wondfo Biotech
  • YZY Biopharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Tumor Fluid Biopsy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 CTDNA Detection
  5. 1.2.3 CTC Detection
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Tumor Fluid Biopsy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Third Party Organization
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Tumor Fluid Biopsy Growth Trends by Region
  14. 1.5.1 Global Tumor Fluid Biopsy Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Tumor Fluid Biopsy Market Size by Region (2021-2026)
  16. 1.5.3 Tumor Fluid Biopsy Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Tumor Fluid Biopsy Market Dynamics
  1. 2.1 Tumor Fluid Biopsy Industry Trends
  2. 2.2 Tumor Fluid Biopsy Industry Drivers
  3. 2.3 Tumor Fluid Biopsy Industry Opportunities and Challenges
  4. 2.4 Tumor Fluid Biopsy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Tumor Fluid Biopsy Revenue by Company (2021-2026)
  2. 3.2 Global Tumor Fluid Biopsy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Tumor Fluid Biopsy Key Company Head office and Area Served
  4. 3.4 Global Tumor Fluid Biopsy Company, Product Type & Application
  5. 3.5 Global Tumor Fluid Biopsy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Tumor Fluid Biopsy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Tumor Fluid Biopsy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Tumor Fluid Biopsy Tier 1, Tier 2, and Tier 3
4 Tumor Fluid Biopsy Market by Type
  1. 4.1 Global Tumor Fluid Biopsy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Tumor Fluid Biopsy Market Size by Type (2021-2032)
  3. 4.3 Global Tumor Fluid Biopsy Market Size Share by Type (2021-2032)
5 Tumor Fluid Biopsy Market by Application
  1. 5.1 Global Tumor Fluid Biopsy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Tumor Fluid Biopsy Market Size by Application (2021-2032)
  3. 5.3 Global Tumor Fluid Biopsy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Cellmax Life
  2. 6.1.1 Cellmax Life Company Information
  3. 6.1.2 Cellmax Life Business Overview
  4. 6.1.3 Cellmax Life Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Cellmax Life Tumor Fluid Biopsy Product Portfolio
  6. 6.1.5 Cellmax Life Recent Developments
  7. 6.2 Exact Science
  8. 6.2.1 Exact Science Company Information
  9. 6.2.2 Exact Science Business Overview
  10. 6.2.3 Exact Science Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Exact Science Tumor Fluid Biopsy Product Portfolio
  12. 6.2.5 Exact Science Recent Developments
  13. 6.3 Amoy Diagnostics Co
  14. 6.3.1 Amoy Diagnostics Co Company Information
  15. 6.3.2 Amoy Diagnostics Co Business Overview
  16. 6.3.3 Amoy Diagnostics Co Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Amoy Diagnostics Co Tumor Fluid Biopsy Product Portfolio
  18. 6.3.5 Amoy Diagnostics Co Recent Developments
  19. 6.4 Berry Genomics Co
  20. 6.4.1 Berry Genomics Co Company Information
  21. 6.4.2 Berry Genomics Co Business Overview
  22. 6.4.3 Berry Genomics Co Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Berry Genomics Co Tumor Fluid Biopsy Product Portfolio
  24. 6.4.5 Berry Genomics Co Recent Developments
  25. 6.5 Genetronhealth
  26. 6.5.1 Genetronhealth Company Information
  27. 6.5.2 Genetronhealth Business Overview
  28. 6.5.3 Genetronhealth Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Genetronhealth Tumor Fluid Biopsy Product Portfolio
  30. 6.5.5 Genetronhealth Recent Developments
  31. 6.6 GenoploRare
  32. 6.6.1 GenoploRare Company Information
  33. 6.6.2 GenoploRare Business Overview
  34. 6.6.3 GenoploRare Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 GenoploRare Tumor Fluid Biopsy Product Portfolio
  36. 6.6.5 GenoploRare Recent Developments
  37. 6.7 HaploX Biotechnology Co
  38. 6.7.1 HaploX Biotechnology Co Company Information
  39. 6.7.2 HaploX Biotechnology Co Business Overview
  40. 6.7.3 HaploX Biotechnology Co Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 HaploX Biotechnology Co Tumor Fluid Biopsy Product Portfolio
  42. 6.7.5 HaploX Biotechnology Co Recent Developments
  43. 6.8 New Horizon Health Limited
  44. 6.8.1 New Horizon Health Limited Company Information
  45. 6.8.2 New Horizon Health Limited Business Overview
  46. 6.8.3 New Horizon Health Limited Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 New Horizon Health Limited Tumor Fluid Biopsy Product Portfolio
  48. 6.8.5 New Horizon Health Limited Recent Developments
  49. 6.9 Burning Rock Biotech
  50. 6.9.1 Burning Rock Biotech Company Information
  51. 6.9.2 Burning Rock Biotech Business Overview
  52. 6.9.3 Burning Rock Biotech Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Burning Rock Biotech Tumor Fluid Biopsy Product Portfolio
  54. 6.9.5 Burning Rock Biotech Recent Developments
  55. 6.10 Guangzhou Wondfo Biotech
  56. 6.10.1 Guangzhou Wondfo Biotech Company Information
  57. 6.10.2 Guangzhou Wondfo Biotech Business Overview
  58. 6.10.3 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Product Portfolio
  60. 6.10.5 Guangzhou Wondfo Biotech Recent Developments
  61. 6.11 YZY Biopharma
  62. 6.11.1 YZY Biopharma Company Information
  63. 6.11.2 YZY Biopharma Business Overview
  64. 6.11.3 YZY Biopharma Tumor Fluid Biopsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 YZY Biopharma Tumor Fluid Biopsy Product Portfolio
  66. 6.11.5 YZY Biopharma Recent Developments
7 North America
  1. 7.1 North America Tumor Fluid Biopsy Market Size (2021-2032)
  2. 7.2 North America Tumor Fluid Biopsy Market Size by Type
  3. 7.2.1 North America Tumor Fluid Biopsy Market Size by Type (2021-2026)
  4. 7.2.2 North America Tumor Fluid Biopsy Market Size by Type (2027-2032)
  5. 7.2.3 North America Tumor Fluid Biopsy Market Share by Type (2021-2032)
  6. 7.3 North America Tumor Fluid Biopsy Market Size by Application
  7. 7.3.1 North America Tumor Fluid Biopsy Market Size by Application (2021-2026)
  8. 7.3.2 North America Tumor Fluid Biopsy Market Size by Application (2027-2032)
  9. 7.3.3 North America Tumor Fluid Biopsy Market Share by Application (2021-2032)
  10. 7.4 North America Tumor Fluid Biopsy Market Size by Country
  11. 7.4.1 North America Tumor Fluid Biopsy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Tumor Fluid Biopsy Market Size by Country (2021-2026)
  13. 7.4.3 North America Tumor Fluid Biopsy Market Size by Country (2027-2032)
  14. 7.4.4 North America Tumor Fluid Biopsy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Tumor Fluid Biopsy Market Size (2021-2032)
  2. 8.2 Europe Tumor Fluid Biopsy Market Size by Type
  3. 8.2.1 Europe Tumor Fluid Biopsy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Tumor Fluid Biopsy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Tumor Fluid Biopsy Market Share by Type (2021-2032)
  6. 8.3 Europe Tumor Fluid Biopsy Market Size by Application
  7. 8.3.1 Europe Tumor Fluid Biopsy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Tumor Fluid Biopsy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Tumor Fluid Biopsy Market Share by Application (2021-2032)
  10. 8.4 Europe Tumor Fluid Biopsy Market Size by Country
  11. 8.4.1 Europe Tumor Fluid Biopsy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Tumor Fluid Biopsy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Tumor Fluid Biopsy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Tumor Fluid Biopsy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Tumor Fluid Biopsy Market Size (2021-2032)
  2. 9.2 China Tumor Fluid Biopsy Market Size by Type
  3. 9.2.1 China Tumor Fluid Biopsy Market Size by Type (2021-2026)
  4. 9.2.2 China Tumor Fluid Biopsy Market Size by Type (2027-2032)
  5. 9.2.3 China Tumor Fluid Biopsy Market Share by Type (2021-2032)
  6. 9.3 China Tumor Fluid Biopsy Market Size by Application
  7. 9.3.1 China Tumor Fluid Biopsy Market Size by Application (2021-2026)
  8. 9.3.2 China Tumor Fluid Biopsy Market Size by Application (2027-2032)
  9. 9.3.3 China Tumor Fluid Biopsy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Tumor Fluid Biopsy Market Size (2021-2032)
  2. 10.2 Asia Tumor Fluid Biopsy Market Size by Type
  3. 10.2.1 Asia Tumor Fluid Biopsy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Tumor Fluid Biopsy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Tumor Fluid Biopsy Market Share by Type (2021-2032)
  6. 10.3 Asia Tumor Fluid Biopsy Market Size by Application
  7. 10.3.1 Asia Tumor Fluid Biopsy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Tumor Fluid Biopsy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Tumor Fluid Biopsy Market Share by Application (2021-2032)
  10. 10.4 Asia Tumor Fluid Biopsy Market Size by Country
  11. 10.4.1 Asia Tumor Fluid Biopsy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Tumor Fluid Biopsy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Tumor Fluid Biopsy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Tumor Fluid Biopsy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Tumor Fluid Biopsy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Tumor Fluid Biopsy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Tumor Fluid Biopsy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Tumor Fluid Biopsy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Tumor Fluid Biopsy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst